# GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

> clinical trial · VERIFIED · 2026-08-10

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Huntington Disease

- Company: Hoffmann-La Roche
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT05686551

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.